| Wendy Morgan, MS, CCC-SLP | |
|
527 Memorial Dr, Pocatello, ID 83201-4063 | |
| (208) 478-3343 | |
| Not Available |
| Full Name | Wendy Morgan |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 527 Memorial Dr, Pocatello, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205035482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-1280 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Morgan, MS, CCC-SLP 527 Memorial Dr, Pocatello, ID 83201-4063 Ph: (208) 478-3343 | Wendy Morgan, MS, CCC-SLP 527 Memorial Dr, Pocatello, ID 83201-4063 Ph: (208) 478-3343 |
News Archive
Data presented today at the 11th Congress of European Crohn's and Colitis Organisation adds to the growing body of real-world evidence that supports switching patients from reference infliximab to biosimilar infliximab.
Pinning down how genetics contributes to behavior is slippery business. For instance, identifying the genes linked to a likelihood of developing schizophrenia or autism could stigmatize those who possess the genes, and may even play a role in defining the conditions themselves.
On any day at three of Massachusetts General Hospital's outpatient clinics, up to 100 patients may be seen for routine, sick or urgent care. When they register, patients 18 and older are asked to wear a wrist coil with an active-RFID tag. Compliance is virtually 100 percent once patients understand the purpose: to help care providers find ways to spend more time providing better care.
A new type of targeting chaperon protein HSP70 inhibitor QL47 was recently discovered by a team led by Prof. LIU Qingsong from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences to treat FLT3-ITD-positive acute myeloid leukemia (AML).
Codexis, Inc., a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States Patent and Trademark Office (USPTO) has granted Codexis' patent covering the biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of leading hepatitis-C therapeutics.
› Verified 9 days ago
Mrs. Molly Lee Hill, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 611 Wilson Ave Ste 6c, Pocatello, ID 83201 Phone: 208-530-0872 | |
Beth Agres, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1001 N 7th Ave, Pocatello, ID 83201 Phone: 208-239-1490 | |
Kami Anne Westover, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 4b, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Cheryl Zaremba, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 896 Lucille Ave, Pocatello, ID 83201 Phone: 208-234-7302 | |
Mr. James Ellis Williams Ii, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 527 Memorial Dr, Pocatello, ID 83201 Phone: 801-419-8096 | |
Mrs. Heather L. Rogers, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1110 Call Creek Dr Ste 7, Pocatello, ID 83201 Phone: 208-233-4660 Fax: 208-233-4262 | |
Amanda Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1071 Renee Ave, Pocatello, ID 83201 Phone: 208-233-1411 |